Sympathetic and baroreflex function in hypertension: Implications for current and new drugs

Current Pharmaceutical Design

Volumn 10, Issue 29, 2004, Pages 3579-3589

  Grassi, Guido ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b Ctro InterUniv di Fisiol Clinica   (Italy)

Author keywords

Antihypertensive agents; Antihypertensive treatment; Arterial baroreflex; End organ damage; Insulin resistance; Sympathetic activity

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; LERCANIDIPINE; METHYLDOPA; MOXONIDINE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PRAZOSIN; RILMENIDINE; URAPIDIL;

ADRENERGIC SYSTEM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE COURSE; ENDOTHELIUM LESION; ESSENTIAL HYPERTENSION; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INSULIN RESISTANCE; KIDNEY FAILURE; METABOLIC DISORDER; MORTALITY; PATHOPHYSIOLOGY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REVIEW; SYMPATHETIC REFLEX; SYMPATHETIC TONE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BAROREFLEX; DRUG DESIGN; HUMANS; HYPERTENSION; SYMPATHETIC NERVOUS SYSTEM;

EID: 6344289585     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043382756     Document Type: Review

References (61)

1. Grassi G. The sympathetic nervous system in hypertension. J Hypertens 1998; 16: 1979-1988.
2. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999; 34: 724-728.
3. Esler M. The sympathetic system in hypertension. Am J Hypertens 2000; 13: 99S-105S.
4. Brook RD, Julius S. Autonomic imbalance, hypertension and cardiovascular risk. Am J Hypertens 2000; 13: 112S-122S.
5. Julius S. The evidence for a pathophysiological significance of the sympathetic overactivity in hypertension. Clin Exp Hypertens 1996; 18: 305-321.
6. Goldstein DS. Plasma catecholamines and essential hypertension: an analytical review. Hypertension 1983; 5: 86-99.
7. Grassi G, Esler MD. How to assess sympathetic activity in humans. J Hypertens 1999; 17: 719-734.
8. Esler M, Lambert G, Jennings G. Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens 1989; 11(Suppl 1): 75-89.
9. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 1988; 14: 1277-1283.
10. Yamada Y, Miyaima E, Tockikubo O, Matsukawa T, Shionoiri H, Ishii M, et al. Impaired baroreflex changes in muscle sympathetic nerve activity in adolescent who have a family history of essential hypertension. J Hypertens 1988; 6 (suppl 4): s526-s528.
11. Floras JS, Hara K. Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension. J Hypertens 1993; 11: 647-655.
12. Smith PA, Graham LN, Mackintosh AF, Stoker JB, Mary DASG. Sympathetic neural mechanisms in white-coat hypertension. J Am Coll Cardiol 2002; 40: 126-132.
13. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998; 81: 68-72.
14. Grassi G, Seravalle G, Bertinieri G, Turri C, Dell'Oro R, Stella ML, et al. Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly. J Hypertens 2000; 18: 587-593.
15. Grassi G, Seravalle G, Turri C, Mancia G. Sympathetic nerve traffic responses to surgical removal of pheochromocytoma. Hypertension 1999; 34: 461-465.
16. De Champlain J. Pre- and post-synaptic adrenergic dysfunctions in hypertension. J Hypertens 1990; 8 (suppl 7): s77-s85.
17. Groppelli A, Giorgi DMA, Ombroni S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992; 10: 495-499.
18. Grassi G, Seravalle G, Calhoun DA, Bolla G, Giannattasio C, Marabini M, et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994; 90: 248-253.
19. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, et al. Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25: 560-563.
20. Grassi G, Seravalle G, Dell'Oro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 2000; 36: 538-542.
21. Scherrrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994; 89: 2634-2640.
22. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96: 3423-3429.
23. Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity and congestive heart failure. Hypertension 1998; 31: 64-67.
24. Wolk R, Shamsuzzaman AS, Somers VK. Obesity, sleep apnea and hypertension. Hypertension 2003; 42: 1067-1074.
25. Scherrer U, Sartori C. Insulin as a vascular and sympathoexitatory hormone. Circulation 1997; 96: 4104-4113.
26. Grassi G, Elam M. Leptin, sympathetic and baroreflex function: another step on the road to sympathetic differentiation. J Hypertens 2002; 20: 1487-1489.
27. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993; 21: 618-623.
28. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, et al. Plasma level and gene polymorphism of angiotensin converting-enzyme in relation to myocardial infarction. Circulation 1994; 90: 669-676.
29. Mancia G, Saino A, Grassi G. Interactions between the sympathetic nervous system and renin angiotensin system. In: Laragh JH, Brenner BM, Eds, Hypertension: Pathophysiology, Diagnosis and Management. New York, Raven Press 1996; 399-408.
30. Mancia G, Grassi G, Ferrari AU. Reflex control of the circulation in experimental and human hypertension. In: Zanchetti A, Mancia G, Eds, Handbook of Hypertension. Vol. 17, Pathophysiology of Hypertension. Amsterdam, Elsevier Science 1997; 568-601.
31. Saino A, Pomidossi G, Perondi R, Valentini R, Rimini A, Di Francesco L, et al. Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in man. Circulation 1997; 96: 148-153.
32. Saino A, Pomidossi G, Perondi R, Morganti A, Turolo L, Mancia G. Modulation of sympathetic coronary vasoconstriction by cardiac renin-angiotensin system in human coronary heart disease. Circulation 2000; 101: 2277-2283.
33. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, et al. Sympathetic nerve activity in end-stage renal disease. Circulation 2002; 106: 1974-1979.
34. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995; 92: 3206-3211.
35. Ramirez AJ, Bertinieri G, Belli L, Cavallazzi A, Di Rienzo M, Pedotti A, et al. Reflex control of blood pressure and heart rate by arterial baroreceptors and by cardiopulmonary receptors in the unanesthetized rat. J Hypertens 1985; 3: 327-335.
36. Mancia G, Parati G, Pomidossi G, Casadei R, Di Rienzo M, Zanchetti A. Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension 1986; 8: 147-153.
37. Bertinieri G, Di Rienzo G, Cavallazzi A, Ferrari AU, Pedotti A, Mancia G. Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats. Am J Physiol 1988; 254: H377-H383.
38. Parati G, Di Rienzo M, Bertinieri G, Pomidossi G, Casadei R, Groppelli A, et al. Evaluation of the baroreceptor-heart rate reflex by 24 hour intra-arterial blood pressure monitoring in humans. Hypertension 1988; 12: 214-222.
39. Rocco MB, Nadel EG, Selvyn AP. Circadian rhythms and coronary artery disease. Am J Cardiol 1987; 69: 13C-17C.
40. White WS, Dey HM, Sculman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild to moderate hypertension. Am Heart J 1989; 118: 782-795.
41. Devereux R, Pickering TG, Harshfiled GA, Kleinert HD, Denby L, Clark L, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 1983; 68: 470-476.
42. Verdecchia P, Schillaci G, Gatteschi C, Zampi I, Battistelli M, Bartoccini C, et al. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular events. Circulation 1993; 88: 986-992.
43. Sen S, Trazi RC, Khairallah P, Bumpus M. Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 1974, 35: 775-781.
44. Heagerty AM. Structural changes in resistance arteries in hypertension. In: Zanchetti A, Mancia G, eds, Handbook of Hypertension, Vol. 17, Pathophysiology of Hypertension. Amsterdam, Elsevier Science; 1997: 426-437.
45. Failla M, Grappiolo A, Emanuelli G, Vitale G, Fraschini N, Bigoni M, et al. Sympathetic tone restrains radial artery distensibility of healthy and atherosclerotic subjects. J Hypertens 1999; 17: 117123.
46. Mircoli L, Mangoni AA, Giannattasio C, Mancia G, Ferrari AU. Heart rate dependent stiffening of large arteries in intact and sympathectomized rats. Hypertension 1999, 34: 598-602
47. Giannattasio C, Vincenti A, Failla M, Capra A, Cirò A, De Ceglia S, et al. Effects of heart rate changes on arterial distensibility in humans. Hypertension 2003; 42: 253-256.
48. Meredith IT, Broughton A, Jennings GL, Ester MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991; 325: 618-624.
49. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med 1984; 311: 819-823.
50. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105: 1354-1359.
51. Grassi G. Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options. Curr Hypertens Rep 2003; 5: 277-280.
52. Grassi G, Seravalle G, Stella ML, Turri C, Zanchetti A, Mancia G. Sympathoexcitatory responses to the acute blood pressure fall induced by central or peripheral antihypertensive drugs. Am J Hypertens 2000; 13: 29-34.
53. Grassi G, Seravalle G, Turri C, Bolla G, Mancia G. Short- versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension. Hypertension 2003; 41: 558-562.
54. Grassi G, Turri C, Dell'Oro R, Stella ML, Bolla GB, Mancia G. Effects of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of cirsulation in essential hypertension. J Hypertens 1998; 16: 1789-1796.
55. Grassi G, Seravalle G, Dell'Oro R, Trevano FQ, Bombelli M, Scopelliti F, et al. for the CROSS Study Group. Comparative effects of Candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity and sympathetic drive in obese hypertensive individuals: results of the CROSS Study. J Hypertens 2003; 21: 1761-1769.
56. Van Zwieten PA. Centrally acting antihypertensives: a renaissance of interest: mechanisms and hemodynamics. J Hypertens 1997; 15(suppl 1): S3-S8.
57. Safar ME, Laurent S, Rilmenide. In cardiovascular Drug Therapy, 2nd edn. Edited by Messerli FH, Philadelphia: WB Saunders; 1996: 633-642.
58. Prichard BNC, Graham BR. The use of moxonidine in the treatment of hypertension. J Hypertens 1997; 15(Suppl 1): S47-S56.
59. Afifi Y, Churchill D. Pharmacological treatment of hypertension in pregnancy. Curr Pharm Design 2003; 9(21): 1745-53.
60. Behnia R, Molteni A, Igic R. Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice. Curr Pharm Design 2003; 9(9): 763-76.
61. Lombardi F, Terranova P. Hypertension and concurrent arrhythmias. Curr Pharm Design 2003; 9(21): 1703-13.